Our Portfolio

Deerfield portfolio companies strive to advance healthcare in meaningful and innovative ways.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Industry
Clear
Purpose of Financing
Clear
Stage
Clear
Structure of Financing
Clear
Status of Investment
Clear
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tag
:
Tag
Showing 0 of 100
Medical Microinstruments
Medical Microinstruments
Medical Technologies
Mar 2022
Venture
Mid Stage
Equity
Current
Lunair Medical
Lunair Medical
Medical Technologies
Jun 2023
Venture
Early Stage
Equity
Current
Liquid Wire
Liquid Wire
Medical Technologies
Mar 2020
Venture
Early Stage
Equity
Current
InCarda Therapeutics
InCarda Therapeutics
Medical Technologies
May 2018
Venture
Early Stage
Equity
Current
Insilico Medicine
Insilico Medicine
Therapeutics
Jun 2021
Growth
Mid Stage
Equity
Current
LetsGetChecked | Fuze Health
LetsGetChecked | Fuze Health
Healthcare Services
Apr 2020
Growth
Mid Stage
Equity
Current
Lark Technologies
Lark Technologies
Healthcare Services
Aug 2021
Growth
Early Stage
Equity
Current
Larimar Therapeutics
Larimar Therapeutics
Therapeutics
Nov 2016
Venture
Seed/Startup
Equity
Current
Jaguar Gene Therapy
Jaguar Gene Therapy
Therapeutics
Mar 2020
Venture
Seed/Startup
Equity
Current
Intus Care
Intus Care
Healthcare Services
Sep 2022
Venture
Early Stage
Equity
Current
HilleVax
HilleVax
Therapeutics
Aug 2021
Growth
Late Stage
Debt
Current
Headspace
Headspace
Healthcare Services
Aug 2015
Venture
Mid Stage
Equity
Current
Edgewise Therapeutics
Edgewise Therapeutics
Therapeutics
Aug 2019
Venture
Early Stage
Equity
Current
Endologix
Endologix
Medical Technologies
Apr 2017
Growth
Growth
Debt and Equity
Current
Frontier Medicines
Frontier Medicines
Therapeutics
Apr 2019
Venture
Seed/Startup
Equity
Current
DISCLAIMER

The portfolio companies shown represents a significant portion of the current portfolio of Deerfield funds utilizing the Private Design Strategy or Healthcare Innovations Strategy.  Exclusions include historical investments, research projects and related entities, companies in stealth mode, companies without material operations, companies in which Deerfield funds hold residual interests, investments in other funds, and investment portfolios of other Deerfield strategies. The specific portfolio companies identified are not representative of all of the portfolio companies purchased, sold, or recommended for Deerfield funds, and it should not be assumed that any investment in an identified portfolio company was or will be profitable. Actual holdings will vary for each Deerfield fund and there is no guarantee that a particular Deerfield fund will hold any or all of the portfolio companies listed.